|
McManus, L M; Bloodworth, R C; Prihoda, T J et al. (2001) Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 70:395-404
|
|
McManus, L M; Pinckard, R N (2000) PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med 11:240-58
|
|
Weintraub, S T; Satsangi, R K; Sprague, E A et al. (2000) Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride. J Am Soc Mass Spectrom 11:176-81
|
|
Pinckard, R N; Prihoda, T J (1996) Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production. J Leukoc Biol 59:219-28
|
|
Woodard, D S; Mealey, B L; Lear, C S et al. (1995) Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride. Biochim Biophys Acta 1259:137-47
|
|
Woodard, D S; Ostrom, K K; McManus, L M (1995) Lipid inhibitors of platelet-activating factor (PAF) in normal human plasma. J Lipid Mediat Cell Signal 12:11-28
|
|
Pinckard, R N; Woodard, D S; Showell, H J et al. (1994) Structural and (patho)physiological diversity of PAF. Clin Rev Allergy 12:329-59
|
|
Weintraub, S T; Lear, C; Pinckard, R N (1993) Differential electron capture mass spectral response of pentafluorobenzoyl derivatives of platelet activating factor alkyl chain homologs. Biol Mass Spectrom 22:559-64
|
|
McManus, L M; Woodard, D S; Deavers, S I et al. (1993) PAF molecular heterogeneity: pathobiological implications. Lab Invest 69:639-50
|
|
McManus, L M; Ostrom, K K; Lear, C et al. (1993) Radiation-induced increased platelet-activating factor activity in mixed saliva. Lab Invest 68:118-24
|
Showing the most recent 10 out of 36 publications
